and Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina

about

and Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina

Item

http://www.wikidata.org/entity/Q58727997

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

and Mutations Other Than the F ...... in the Population of Argentina

@en

and Mutations Other Than the F ...... in the Population of Argentina

@nl

type

Item

label

and Mutations Other Than the F ...... in the Population of Argentina

@en

and Mutations Other Than the F ...... in the Population of Argentina

@nl

prefLabel

and Mutations Other Than the F ...... in the Population of Argentina

@en

and Mutations Other Than the F ...... in the Population of Argentina

@nl

P1476

and Mutations Other Than the F ...... in the Population of Argentina

@en

P2093

Alejandra Mampel

http://www.w3.org/2001/XMLSchema#string

Angela R Solano

http://www.w3.org/2001/XMLSchema#string

Daniela M Faggionato

http://www.w3.org/2001/XMLSchema#string

Ernesto J Podesta

http://www.w3.org/2001/XMLSchema#string

Fernanda S Jalil

http://www.w3.org/2001/XMLSchema#string

Florencia C Cardoso

http://www.w3.org/2001/XMLSchema#string

Natalia C Liria

http://www.w3.org/2001/XMLSchema#string

Pablo G Mele

http://www.w3.org/2001/XMLSchema#string

P2860

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.

Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.

High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.

P304

323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00323

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186769

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6113569

http://www.w3.org/2001/XMLSchema#string